Literature DB >> 19120352

Weekly imatinib dosage for chronic eosinophilic leukaemia expressing FIP1L1-PDGFRA fusion transcript: extended follow-up.

Grzegorz Helbig, Andrzej Moskwa, Alina Swiderska, Alina Urbanowicz, Małgorzata Całbecka, Justyna Gajkowska, Barbara Zdziarska, Katarzyna Brzeźniakiewicz, Joanna Pogrzeba, Sławomira Krzemień.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19120352     DOI： 10.1111/j.1365-2141.2008.07546.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  4 in total

Review 1.  Hypereosinophilic syndrome and clonal eosinophilia: point-of-care diagnostic algorithm and treatment update.

Authors:  Ayalew Tefferi; Jason Gotlib; Animesh Pardanani
Journal:  Mayo Clin Proc       Date:  2010-01-06       Impact factor: 7.616

2.  Durable remission after treatment with very low doses of imatinib for FIP1L1-PDGFRα-positive chronic eosinophilic leukaemia.

Authors:  Grzegorz Helbig; Andrzej Moskwa; Marek Hus; Jarosław Piszcz; Alina Swiderska; Alina Urbanowicz; Małgorzata Całbecka; Ilona Seferyńska; Małgorzata Raźny; Marek Rodzaj; Ewa Żuk; Sławomira Kyrcz-Krzemień
Journal:  Cancer Chemother Pharmacol       Date:  2011-02-17       Impact factor: 3.333

3.  FIP1L1-PDGFRA-Positive Chronic Eosinophilic Leukemia: A Low-Burden Disease with Dramatic Response to Imatinib - A Report of 5 Cases from South India.

Authors:  Anıl N Kumar; Vishwanath Sathyanarayanan; Visweswariah Lakshmi Devi; Namratha N Rajkumar; Umesh Das; Sarjana Dutt; Lakshmaiah K Chinnagiriyappa
Journal:  Turk J Haematol       Date:  2014-03-05       Impact factor: 1.831

4.  The Spectrum of FIP1L1-PDGFRA-Associated Chronic Eosinophilic Leukemia: New Insights Based on a Survey of 44 Cases.

Authors:  Fanny Legrand; Aline Renneville; Elizabeth MacIntyre; Samuel Mastrilli; Felix Ackermann; Jean Michel Cayuela; Philippe Rousselot; Aline Schmidt-Tanguy; Olivier Fain; Marc Michel; Jean-Pierre de Jaureguiberry; Pierre-Yves Hatron; Pascale Cony-Makhoul; Didier Lefranc; Damien Sène; Vincent Cottin; Mohamed Hamidou; Olivier Lidove; André Baruchel; Sylvain Dubucquoi; Olivier Bletry; Claude Preudhomme; Monique Capron; Lionel Prin; Jean Emmanuel Kahn
Journal:  Medicine (Baltimore)       Date:  2013-09       Impact factor: 1.889
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.